PRR11 and neoplasm: Subsequently, we performed validation of the clinical samples, and the PRR11 expression levels of the three patients after recurrence were further elevated compared with those at the initial diagnosis, and the tumor T‐stage and pathological grading also confirmed the progression of the tumors (Figure 2F).